Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Katsura Tsukamoto"'
Autor:
Naoki Matsumaru, Hideshi Okada, Kodai Suzuki, Sho Nachi, Takahiro Yoshida, Katsura Tsukamoto, Shinji Ogura
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 1, Pp 1-10 (2020)
Background: Stroke has been found to have a seasonally varying incidence; blood pressure, one of its risk factors, is influenced by humidity and temperature. The relationship between the incidence of stroke and meteorological parameters remains contr
Externí odkaz:
https://doaj.org/article/d224c73202e14c23986a187a69086d5f
Publikováno v:
YAKUGAKU ZASSHI. 142:1399-1407
Decisions concerning approval of human papillomavirus (HPV) vaccines and their use are based on expert evaluation of the vaccines. However, the quantitative differences between vaccine benefits and risks are difficult for non-experts to understand. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c37029a76715fdc5c30592a74619c7d
https://doi.org/10.1248/yakushi.22-00142
https://doi.org/10.1248/yakushi.22-00142
Publikováno v:
Clinical Pharmacology & Therapeutics. 112:817-823
Compassionate use is a system that provides patients with exceptional access to investigational new drugs to treat life-threatening diseases that have no effective conventional treatments. The purpose of this study was to characterize and assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697b1ca984e4a841f7cdd77bb691f831
https://doi.org/10.1002/cpt.2641
https://doi.org/10.1002/cpt.2641
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:1395-1401
Regulatory authorities in several regions have introduced a number of expedited programs (EPs) to promote the development of innovative drugs for patients in their own countries. The EPs in the United States (US), alone or in combination, have been s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef8fa14340bfac402ebf6f9667d3c5d
https://doi.org/10.1111/jcpt.13677
https://doi.org/10.1111/jcpt.13677
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 46:1582-1590
WHAT IS KNOWN AND OBJECTIVE Drug development is generally a long and expensive process. Regulatory authorities have established several expedited regulatory pathways, such as accelerated approval designation in the United States (1992) and conditiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9bf6851c332dc467f4750972a3c3e1
https://doi.org/10.1111/jcpt.13487
https://doi.org/10.1111/jcpt.13487
Publikováno v:
Pharmaceutical Medicine. 35:253-260
Drug time lags occur between the date that new drugs are first approved, often in the USA, and approval is granted in other countries. Multi-regional clinical trials (MRCTs) are a key strategy for simultaneous global development and regulatory submis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a971bf3ec87d458c6a4059852fb5ed6
https://doi.org/10.1007/s40290-021-00393-w
https://doi.org/10.1007/s40290-021-00393-w
Autor:
Hiroyuki Sakamaki, Katsura Tsukamoto, Motoaki Yoshino, Shinya Ohno, Yirong Chen, Naoki Matsumaru
Publikováno v:
Journal of Medical Economics. 24:266-278
The growing prevalence of Alzheimer's disease (AD) worldwide has sparked the implementation of national policies to support the growing burden among caregivers of AD/dementia patients. This study aims to quantify and compare the burden of AD/dementia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31757e52cb02250c940bcea1e188b719
https://doi.org/10.1080/13696998.2021.1880801
https://doi.org/10.1080/13696998.2021.1880801
Publikováno v:
Biologicalpharmaceutical bulletin. 45(4)
Early access to novel drugs, regardless of regional differences, is significant for patients worldwide. Although various efforts have been made to reduce the drug lag, it still exists in some regions, including Japan. In this study, we focused on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c64ce5515e6d006d94ed68e0a95abb
https://pubmed.ncbi.nlm.nih.gov/35370272
https://pubmed.ncbi.nlm.nih.gov/35370272
Autor:
Katsura Tsukamoto, Sho Nachi, Shinji Ogura, Naoki Matsumaru, Hideshi Okada, Kodai Suzuki, Takahiro Yoshida
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 1, Pp 1-10 (2020)
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra
Background: Stroke has been found to have a seasonally varying incidence; blood pressure, one of its risk factors, is influenced by humidity and temperature. The relationship between the incidence of stroke and meteorological parameters remains contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b45ab2e5260653368d8a111f479dad
https://www.karger.com/Article/FullText/505122
https://www.karger.com/Article/FullText/505122
Publikováno v:
BPB Reports. 3:157-165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77223377782509b7d2971c7960f8d26f
https://doi.org/10.1248/bpbreports.3.5_157
https://doi.org/10.1248/bpbreports.3.5_157